Serious and Progressive Neuropathy Presumably Post-Shingrix Vaccination
We present a case of serious and progressive neuropathy shortly following the administration of the herpes zoster subunit (HZ/su) vaccine, otherwise known as Shingrix. The progressive neuropathy occurred a week following the vaccination and progressed until discharge 16 days post-admittance. The pat...
Main Authors: | Michael J. Wons, Avani Vaghela, Amna Khalid, Benjamin D. Brooks |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2571-841X/7/1/5 |
Similar Items
-
Prolonged Neurological and Musculoskeletal Symptoms Following Shingrix Vaccination
by: Sabrina Hollar, et al.
Published: (2024-10-01) -
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
by: Tracy J. Lu, et al.
Published: (2022-02-01) -
Association of asthma and herpes zoster, the role of vaccination: A literature review
by: Abhigan Babu Shrestha, et al.
Published: (2022-11-01) -
Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques
by: Lulu Huang, et al.
Published: (2024-12-01) -
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster
by: Shun Zhang, et al.
Published: (2025-01-01)